| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |